Roche Holding AG (SWX:RO)

Market Cap	237.12B
Revenue (ttm)	63.49B
Net Income (ttm)	9.43B
Shares Out	n/a
EPS (ttm)	11.74
PE Ratio	25.15
Forward PE	14.51
Dividend	9.70 (3.34%)
Ex-Dividend Date	Mar 27, 2025

Volume	27,387
Average Volume	23,572
Open	293.20
Previous Close	292.40
Day's Range	288.60 - 293.60
52-Week Range	244.00 - 333.60
Beta	0.17
RSI	69.38
Earnings Date	Oct 20, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1896
• Employees: 103,249
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: RO

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.